Compare MRVI & SMWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRVI | SMWB |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.8M | 240.7M |
| IPO Year | 2020 | 2021 |
| Metric | MRVI | SMWB |
|---|---|---|
| Price | $3.80 | $2.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | $4.57 | ★ $8.13 |
| AVG Volume (30 Days) | 1.1M | ★ 1.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $185,743,000.00 | N/A |
| Revenue This Year | $11.80 | $17.15 |
| Revenue Next Year | $7.74 | $14.61 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.67 | $2.22 |
| 52 Week High | $4.11 | $10.75 |
| Indicator | MRVI | SMWB |
|---|---|---|
| Relative Strength Index (RSI) | 69.37 | 24.91 |
| Support Level | $3.65 | $2.22 |
| Resistance Level | $4.03 | $7.92 |
| Average True Range (ATR) | 0.18 | 0.34 |
| MACD | 0.10 | 0.05 |
| Stochastic Oscillator | 92.23 | 23.02 |
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.